Unaltered expression of Fas (CD95/APO-1), Caspase-3, Bcl-2 and Annexins in brains of fetal Down syndrome: Evidence against increased apoptosis

Journal of Neural Transmission, Supplement

Volumn , Issue 61, 2001, Pages 149-162

  Engidawork, E ^a   Balic, N ^a   Juranville, J F ^b   Fountoulakis, M ^b   Dierssen, M ^c   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; BIOCHEMICAL MARKER; CALPHOBINDIN II; CASPASE 3; FAS ANTIGEN; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 5; NEURON SPECIFIC ENOLASE; PROTEIN BCL 2; CASPASE; CPP32 PROTEIN; ONCOPROTEIN; PROTO ONCOGENE PROTEINS C BCL 2;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN SYNDROME; FEMALE; FETUS; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN; CONGENITAL MALFORMATION; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANNEXINS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CASPASES; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETUS; HUMAN; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPPORT, NON-U.S. GOV'T;

EID: 0035232356     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6262-0_12     Document Type: Article

References (51)

1. Adayev T, Estephan R, Meserole S, Mazza B, Yurkow EJ, Banerjee P (1998) Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptosis cells are phagocytosed by microglia. J Neurochem 71: 1854-1864
2. Anderson AJ, Stoltzner S, Lai Florence Su J, Nixon RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer's disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21: 511-524
3. Becher B, Barker PA, Owens T, Antel PJ (1998a) CD95-CD95L: can the brain learn from the immune system? Trends Neurosci 21: 114-117
4. Becher B, D'Souza SD, Troutt AB, Antel JP (1998b) Fas expression on human fetal astrocytes without susceptibility to fas mediated toxicity. Neuroscience 84: 627-634
5. Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521-3526
6. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
7. Busciglio J, Yanker BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome in vitro. Nature 378: 776-779
8. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M (2000) Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin 1). Life Sci 66: PL265-270
9. Chan WY, Yew DT (1998) Apoptosis and Bcl-2 oncoprotein expression in the human fetal central nervous system. Anat Rec 252: 165-175
10. Cheema ZF, West JR, Miranda RC (2000) Ethanol induces Fas/APO mRNA and cell suicide in the developing cerebral cortex. Alcohol Clin Exp Res 24: 535-543
11. Chiang Y, Rizzino A, Sibenaller ZA, Wold MS, Vishwanatha JK (1999) Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 199: 139-147
12. Creutz CE (1992) The annexins and exocytosis. Science 258: 924-931
13. Dragunow M, MacGibbon GA, Lawlor P, Butterworth N, Connor B, Henderson C, Walton M, Woodgate A, Hughes P, Faull RL (1997) Apoptosis, neurotrophic factors and neurodegeneration. Rev Neurosci 8: 223-265
14. Epstein CJ (1995) Down Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn, vol I. McGraw Hill, New York, pp 749-794
15. Fountoulakis M, Langen H (1997) Identification of proteins by matrix assisted laser desorption ionization mass spectrometry following in-gel digestion in low salt, non-volatile buffer and simplified peptide recovery. Anal Biochem 250: 153-156
16. Francis JW, Balazovich KJ, Smolen JE, Margolis DI, Boxer LA (1992) Human neutrophil annexin I promotes granule aggregation and modulates Ca2+ dependent membrane fusion. J Clin Invest 90: 537-544
17. Gidon-Jeangirard C, Hugel B, Holl V, Toti F, Laplanche JL, Meyer D, Freyssinet JM (1999a) Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. J Immunol 162: 5712-5718
18. Gidon-Jeangirard C, Solito E, Hofmann A, Russo-Marie F, Freyssinet JM, Martinez MC (1999b) Annexin V counteracts apoptosis while inducing Ca2+ influx in human lymphocytic T cells. Biochem Biophys Res Commun 265: 709-715
19. Gulesserian T, Engidawork E, Cairns N, Lubec G (2000) Increased serotonin protein levels in frontal cortex of patients with Down syndrome. Neurosci Lett 296: 53-57
20. Gulesserian T, Engidawork E, Yoo BC, Cairns N, Lubec G (2001) Alteration of caspases and their regulatory proteins in brains of Down syndrome. J Neural Transm (this volume)
21. Hutchins JB, Barger SW (1998) Why neurons die: cell death in the nervous system. Anat Rec 253: 79-90
22. Johnson MD, Kamso-Pratt JM, Whetsell WO, Pepinsky RB (1989) Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol 92: 424-429
23. Kaetzel MA, Hazarika P, Dedman JR (1989) Differential distribution of three 35-kDa annexin calcium dependent phospholipid binding proteins. J Biol Chem 264: 14463-14470
24. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 3: 614-620
25. Krosmeyer SJ (1995) Regulators of cell death. Trends Genet 11: 101-105
26. Kuan C-Yi, Roth KA, Flavell RA, Rakic P (2000) Mechanisms of programmed cell death in the developing brain. Trends Neurosci 23: 291-297
27. Langen H, Röder D, Juranville JF, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two dimensional gel electrophoresis. Electrophoresis 18: 2085-2090
28. Maiese K, Vincent AM (2000) Membrane asymmetry and DNA degradation: Functionally distinct determinants of neuronal programmed cell death. J Neurotics 59: 568-580
29. Mann DM (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Aging Div 43: 99-136
30. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR (1995) Early redistribution of plasma membrane phosphatidylserine externalization is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556
31. McKanna JA (1995) Lipocortin I in apoptosis: mammary regression. Anat Rec 242: 1-10
32. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bcl-2 expression is widespread in the developing nervous system and retained in the adult PNS. Development 120: 301-311
33. Osterloh D, Wittbrodt J, Gerke V (1998) Characterization and developmentally regulated expression of four annexins in the killifish medaka: DANN. Cell Biol 17: 835-847
34. Rao L, White E (1997) Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Gene Dev 7: 52-58
35. Raynal P, Pollard MB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid binding proteins. Biochem Biophys Acta 1197: 63-93
36. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, Israel MA (1992) Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52: 6871-6876
37. Reutelingsperger CP, van Heerde WL (1997) Annexin V, the regulator of phosphatidylserine catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 53: 527-532
38. Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS (2000) Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 267: 3220-3225
39. Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F (1996) Modulation of cell death pathways to apoptosis and necrosis of H2O2 treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 220: 643-647
40. Saphier CJ, Yeh J (1998) Altered apoptosis levels in hearts of human fetuses with Down syndrome. Am J Obstet Gynecol 179: 962-965
41. Sawa A, Oyama F, Cairns N, Amano N, Matsushita M (1997) Aberrant expression of Bcl-2 gene family in Down's syndrome brains. Mol Brain Res 48: 53-59
42. Seidl R, Fang-Kircher S, Bidmon B, Cairns N, Lubec G (1999) Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett 260: 9-12
43. Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Biophys Res Commun 256: 381-384
44. Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomasselli KJ (1998) In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Diff 5: 1004-1016
45. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1322
46. Tzima E, Walker JH (2000) Platelet annexin V: the ins and outs. Platelets 11: 542-251
47. Vermes I, Steur EN, Reutelingsperger C, Haanen C (1999) Decreased concentration of annexin V in Parkinsonian cerebrospinal fluid: speculation on the underlying cause. Mov Disord 14: 1008-1010
48. Wang S, Dibenedetto AJ, Pittman RN (1997) Genes induced in programmed cell death of neuronal PC12 cells and developing sympathetic neurons in vivo. Dev Biol 188: 322-336
49. Wang S, Rosengren LE, Franlund M, Hamberger A, Haglid KG (1999) Bcl-2 expression regulates cell sensitivity to S100β mediated apoptosis. Mol Brain Res 70: 167-176
50. Wisniewski KE, Kida E (1994) Abnormal neurogenesis and synaptogenesis in Down syndrome brain. Dev Brain Dysfunct 7: 289-301
51. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome. Ann Neurol 17: 278-282